Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuromyelitis Optica | 60 | 2023 | 252 | 17.440 |
Why?
|
Aquaporin 4 | 25 | 2022 | 153 | 6.410 |
Why?
|
Autoantibodies | 21 | 2023 | 2035 | 2.980 |
Why?
|
Endosonography | 16 | 2023 | 610 | 2.390 |
Why?
|
Ganglia, Sympathetic | 3 | 2019 | 62 | 2.020 |
Why?
|
Immunologic Factors | 10 | 2020 | 1580 | 1.770 |
Why?
|
Pancreatic Neoplasms | 17 | 2023 | 5256 | 1.600 |
Why?
|
Multiple Sclerosis | 17 | 2019 | 3079 | 1.530 |
Why?
|
Siderosis | 5 | 2013 | 102 | 1.450 |
Why?
|
Iron Chelating Agents | 4 | 2019 | 139 | 1.360 |
Why?
|
Hemosiderosis | 2 | 2019 | 71 | 1.250 |
Why?
|
Carcinoma, Pancreatic Ductal | 8 | 2021 | 1634 | 1.090 |
Why?
|
Optic Neuritis | 6 | 2019 | 166 | 1.080 |
Why?
|
Methylprednisolone | 2 | 2019 | 387 | 1.070 |
Why?
|
Myelitis | 2 | 2019 | 53 | 1.050 |
Why?
|
Encephalomyelitis | 3 | 2019 | 34 | 1.010 |
Why?
|
Immunoglobulin G | 13 | 2022 | 4560 | 0.920 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 2 | 2019 | 32 | 0.840 |
Why?
|
Hemosiderin | 2 | 2011 | 43 | 0.800 |
Why?
|
Pancreatic Cyst | 2 | 2021 | 368 | 0.790 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2018 | 835 | 0.750 |
Why?
|
Central Cord Syndrome | 1 | 2019 | 4 | 0.710 |
Why?
|
Pancreatic Diseases | 4 | 2023 | 350 | 0.690 |
Why?
|
Neurodegenerative Diseases | 2 | 2019 | 1061 | 0.680 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2019 | 39 | 0.660 |
Why?
|
Celiac Plexus | 1 | 2018 | 26 | 0.660 |
Why?
|
Cyclobutanes | 1 | 2018 | 59 | 0.650 |
Why?
|
Adenocarcinoma | 4 | 2019 | 6364 | 0.650 |
Why?
|
Plasma Exchange | 2 | 2019 | 152 | 0.640 |
Why?
|
Pancreatic Pseudocyst | 3 | 2009 | 110 | 0.640 |
Why?
|
Antigens, CD20 | 1 | 2019 | 199 | 0.640 |
Why?
|
Spinal Cord | 9 | 2019 | 1809 | 0.640 |
Why?
|
Poliomyelitis | 1 | 2019 | 103 | 0.630 |
Why?
|
Insulinoma | 2 | 2023 | 124 | 0.600 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 134 | 0.580 |
Why?
|
Neuromuscular Diseases | 1 | 2019 | 248 | 0.560 |
Why?
|
Pyridones | 2 | 2011 | 712 | 0.560 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2016 | 111 | 0.550 |
Why?
|
Ampulla of Vater | 1 | 2016 | 141 | 0.540 |
Why?
|
Recurrence | 11 | 2023 | 8340 | 0.540 |
Why?
|
Mycophenolic Acid | 2 | 2017 | 343 | 0.540 |
Why?
|
Demyelinating Diseases | 3 | 2015 | 354 | 0.530 |
Why?
|
Immunosuppressive Agents | 5 | 2021 | 4149 | 0.530 |
Why?
|
Agranulocytosis | 1 | 2015 | 101 | 0.530 |
Why?
|
Jejunostomy | 1 | 2015 | 56 | 0.530 |
Why?
|
Encephalitis | 1 | 2019 | 423 | 0.520 |
Why?
|
Surgical Stomas | 1 | 2015 | 43 | 0.520 |
Why?
|
Humans | 127 | 2023 | 744343 | 0.510 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2019 | 693 | 0.510 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2015 | 1130 | 0.500 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2015 | 187 | 0.490 |
Why?
|
Myelitis, Transverse | 5 | 2019 | 39 | 0.490 |
Why?
|
Complement Pathway, Classical | 1 | 2014 | 97 | 0.490 |
Why?
|
Antibodies | 2 | 2019 | 2460 | 0.460 |
Why?
|
Varicose Veins | 1 | 2015 | 154 | 0.460 |
Why?
|
Complement C4 | 1 | 2014 | 257 | 0.460 |
Why?
|
Disability Evaluation | 7 | 2019 | 1827 | 0.460 |
Why?
|
Patient Care | 1 | 2019 | 640 | 0.450 |
Why?
|
Benzamides | 1 | 2018 | 1379 | 0.440 |
Why?
|
Cholangitis, Sclerosing | 3 | 2021 | 159 | 0.440 |
Why?
|
Adrenal Cortex Hormones | 2 | 2019 | 1855 | 0.440 |
Why?
|
Bile Duct Neoplasms | 3 | 2020 | 567 | 0.440 |
Why?
|
Cholangiocarcinoma | 3 | 2020 | 516 | 0.440 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2009 | 868 | 0.430 |
Why?
|
Optic Nerve | 5 | 2019 | 554 | 0.430 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 307 | 0.430 |
Why?
|
Azathioprine | 1 | 2014 | 353 | 0.430 |
Why?
|
Endoscopy, Digestive System | 2 | 2006 | 345 | 0.430 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 648 | 0.430 |
Why?
|
Disabled Persons | 2 | 2021 | 1212 | 0.420 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.410 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.410 |
Why?
|
Nerve Block | 1 | 2018 | 644 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 19 | 2019 | 35421 | 0.400 |
Why?
|
Middle Aged | 53 | 2023 | 213383 | 0.400 |
Why?
|
Female | 69 | 2023 | 380194 | 0.390 |
Why?
|
Male | 64 | 2023 | 350118 | 0.380 |
Why?
|
Central Nervous System Diseases | 2 | 2013 | 518 | 0.370 |
Why?
|
Lymph Nodes | 3 | 2020 | 3474 | 0.370 |
Why?
|
Treatment Outcome | 23 | 2023 | 63114 | 0.360 |
Why?
|
Retrospective Studies | 31 | 2023 | 77449 | 0.360 |
Why?
|
Adult | 48 | 2023 | 214055 | 0.350 |
Why?
|
Vaccines | 1 | 2018 | 822 | 0.350 |
Why?
|
Immunotherapy | 4 | 2019 | 4445 | 0.340 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1790 | 0.340 |
Why?
|
Cholestasis | 2 | 2023 | 378 | 0.340 |
Why?
|
Aged | 35 | 2022 | 163280 | 0.340 |
Why?
|
Gastritis, Hypertrophic | 1 | 2008 | 9 | 0.330 |
Why?
|
Ablation Techniques | 1 | 2011 | 249 | 0.330 |
Why?
|
Cholestasis, Extrahepatic | 2 | 2008 | 51 | 0.320 |
Why?
|
Brain | 10 | 2019 | 26385 | 0.320 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4851 | 0.300 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 4 | 2021 | 504 | 0.300 |
Why?
|
Drainage | 6 | 2023 | 1142 | 0.300 |
Why?
|
Vitamin D Deficiency | 2 | 2019 | 1343 | 0.290 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15076 | 0.290 |
Why?
|
Ultrasonography, Interventional | 3 | 2023 | 1486 | 0.280 |
Why?
|
Neutrophils | 1 | 2018 | 3719 | 0.270 |
Why?
|
Jaundice | 2 | 2021 | 89 | 0.270 |
Why?
|
Young Adult | 17 | 2019 | 56430 | 0.270 |
Why?
|
Vaccination | 1 | 2018 | 3278 | 0.270 |
Why?
|
Stents | 8 | 2023 | 3280 | 0.270 |
Why?
|
Glucocorticoids | 1 | 2015 | 2107 | 0.260 |
Why?
|
Aged, 80 and over | 16 | 2020 | 57776 | 0.260 |
Why?
|
Health Care Costs | 1 | 2019 | 3209 | 0.260 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1392 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3597 | 0.260 |
Why?
|
Ethanol | 1 | 2011 | 1342 | 0.250 |
Why?
|
Quality of Life | 5 | 2021 | 12804 | 0.250 |
Why?
|
Biopsy | 4 | 2019 | 6756 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3022 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.230 |
Why?
|
Central Nervous System | 2 | 2016 | 1357 | 0.230 |
Why?
|
Diagnosis, Differential | 7 | 2019 | 12959 | 0.230 |
Why?
|
Inflammation | 3 | 2021 | 10638 | 0.230 |
Why?
|
Adolescent | 18 | 2019 | 85781 | 0.220 |
Why?
|
Liver | 2 | 2020 | 7474 | 0.220 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1912 | 0.220 |
Why?
|
Internationality | 2 | 2019 | 1003 | 0.220 |
Why?
|
Vitamin D | 2 | 2019 | 3223 | 0.220 |
Why?
|
Brain Diseases | 1 | 2012 | 1563 | 0.220 |
Why?
|
Biliary Tract Neoplasms | 1 | 2004 | 178 | 0.210 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3674 | 0.210 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9274 | 0.210 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2004 | 198 | 0.210 |
Why?
|
Cytidine | 1 | 2021 | 68 | 0.200 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2023 | 172 | 0.200 |
Why?
|
Encephalomyelitis, Acute Disseminated | 2 | 2019 | 66 | 0.190 |
Why?
|
Hypoglycemia | 2 | 2023 | 861 | 0.190 |
Why?
|
Age of Onset | 3 | 2018 | 3271 | 0.190 |
Why?
|
Child | 14 | 2019 | 77709 | 0.190 |
Why?
|
T-Lymphocytes | 2 | 2016 | 10180 | 0.190 |
Why?
|
Ships | 1 | 2020 | 61 | 0.180 |
Why?
|
Gastric Balloon | 1 | 2020 | 31 | 0.180 |
Why?
|
Dihematoporphyrin Ether | 1 | 2019 | 31 | 0.180 |
Why?
|
Cholecystostomy | 1 | 2019 | 46 | 0.180 |
Why?
|
Child, Preschool | 8 | 2019 | 41006 | 0.180 |
Why?
|
Enterovirus D, Human | 1 | 2019 | 5 | 0.170 |
Why?
|
Oligoclonal Bands | 1 | 2019 | 16 | 0.170 |
Why?
|
Biopsy, Fine-Needle | 2 | 2020 | 1094 | 0.170 |
Why?
|
Biliary Tract Diseases | 2 | 2018 | 161 | 0.170 |
Why?
|
Complement C5 | 1 | 2019 | 112 | 0.170 |
Why?
|
Cholecystitis, Acute | 1 | 2019 | 70 | 0.170 |
Why?
|
Complement Inactivating Agents | 1 | 2019 | 50 | 0.170 |
Why?
|
Area Postrema | 1 | 2018 | 7 | 0.170 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2007 | 1018 | 0.170 |
Why?
|
Swine | 3 | 2018 | 5917 | 0.170 |
Why?
|
Receptors, Interleukin-8B | 1 | 2018 | 59 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Egypt | 1 | 2018 | 100 | 0.160 |
Why?
|
Pancreatic Ducts | 1 | 2020 | 328 | 0.160 |
Why?
|
Enterovirus Infections | 1 | 2019 | 72 | 0.160 |
Why?
|
Pancreatectomy | 1 | 2023 | 804 | 0.160 |
Why?
|
RNA, Messenger | 3 | 2021 | 13033 | 0.160 |
Why?
|
Brachytherapy | 1 | 2006 | 1248 | 0.160 |
Why?
|
JC Virus | 1 | 2018 | 85 | 0.160 |
Why?
|
Disease Progression | 6 | 2020 | 13284 | 0.150 |
Why?
|
Secondary Prevention | 3 | 2019 | 1530 | 0.150 |
Why?
|
Registries | 1 | 2013 | 8089 | 0.150 |
Why?
|
Rats, Inbred Lew | 1 | 2018 | 1162 | 0.150 |
Why?
|
Double-Blind Method | 3 | 2020 | 12026 | 0.140 |
Why?
|
Time Factors | 5 | 2018 | 40075 | 0.140 |
Why?
|
Prospective Studies | 7 | 2023 | 53288 | 0.140 |
Why?
|
Haiti | 1 | 2018 | 553 | 0.140 |
Why?
|
Remission Induction | 2 | 2014 | 2386 | 0.140 |
Why?
|
Incidental Findings | 1 | 2021 | 689 | 0.140 |
Why?
|
Smad4 Protein | 1 | 2016 | 163 | 0.130 |
Why?
|
Drugs, Investigational | 1 | 2018 | 214 | 0.130 |
Why?
|
Electrodes | 1 | 2018 | 619 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 441 | 0.130 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2016 | 145 | 0.130 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14722 | 0.120 |
Why?
|
Gastric Mucosa | 2 | 2008 | 599 | 0.120 |
Why?
|
Retinal Neurons | 1 | 2015 | 66 | 0.120 |
Why?
|
Vomiting | 2 | 2018 | 636 | 0.120 |
Why?
|
Spinal Cord Diseases | 1 | 2017 | 298 | 0.120 |
Why?
|
Age Factors | 3 | 2018 | 18370 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 575 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2022 | 990 | 0.120 |
Why?
|
Postpartum Period | 2 | 2019 | 1086 | 0.120 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2019 | 652 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1813 | 0.120 |
Why?
|
Hiccup | 1 | 2013 | 9 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1170 | 0.120 |
Why?
|
Stromal Cells | 1 | 2019 | 1355 | 0.120 |
Why?
|
Genes, p53 | 1 | 2016 | 755 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3586 | 0.120 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39050 | 0.120 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18029 | 0.110 |
Why?
|
Photochemotherapy | 1 | 2019 | 807 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2649 | 0.110 |
Why?
|
Pilot Projects | 2 | 2019 | 8324 | 0.110 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2016 | 880 | 0.110 |
Why?
|
Palliative Care | 2 | 2006 | 3493 | 0.110 |
Why?
|
Neuralgia | 1 | 2019 | 570 | 0.110 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 246 | 0.110 |
Why?
|
Drug Design | 1 | 2018 | 1076 | 0.110 |
Why?
|
Longitudinal Studies | 3 | 2019 | 13989 | 0.110 |
Why?
|
Antigens, Ly | 1 | 2013 | 291 | 0.110 |
Why?
|
Autoantigens | 1 | 2016 | 892 | 0.110 |
Why?
|
Cohort Studies | 7 | 2023 | 40561 | 0.110 |
Why?
|
Animals | 11 | 2018 | 168757 | 0.100 |
Why?
|
Analgesics | 1 | 2019 | 1040 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6489 | 0.100 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2011 | 39 | 0.100 |
Why?
|
Neoplasm Staging | 4 | 2020 | 11031 | 0.100 |
Why?
|
Survival Analysis | 3 | 2020 | 10252 | 0.100 |
Why?
|
Diazoxide | 1 | 2011 | 57 | 0.100 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 12072 | 0.100 |
Why?
|
Auditory Pathways | 1 | 2013 | 233 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2021 | 2942 | 0.100 |
Why?
|
Calcifediol | 1 | 2011 | 166 | 0.090 |
Why?
|
Tinnitus | 1 | 2013 | 195 | 0.090 |
Why?
|
Research Design | 2 | 2018 | 5987 | 0.090 |
Why?
|
Behavior, Animal | 1 | 2018 | 1881 | 0.090 |
Why?
|
Tomography, Optical Coherence | 4 | 2019 | 2657 | 0.090 |
Why?
|
Pancreas | 3 | 2023 | 1686 | 0.090 |
Why?
|
Antibody Formation | 1 | 2015 | 1402 | 0.090 |
Why?
|
Colectomy | 1 | 2015 | 683 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3870 | 0.090 |
Why?
|
Postmortem Changes | 1 | 2010 | 126 | 0.090 |
Why?
|
Myelin Sheath | 1 | 2013 | 652 | 0.090 |
Why?
|
Nerve Fibers | 1 | 2013 | 687 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2886 | 0.090 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8642 | 0.080 |
Why?
|
Mood Disorders | 1 | 2016 | 1106 | 0.080 |
Why?
|
Metals | 2 | 2023 | 719 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.080 |
Why?
|
Risk Factors | 4 | 2021 | 72290 | 0.080 |
Why?
|
Risk Assessment | 3 | 2018 | 23338 | 0.080 |
Why?
|
Auditory Perception | 1 | 2013 | 569 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2925 | 0.080 |
Why?
|
Protein-Losing Enteropathies | 1 | 2008 | 45 | 0.080 |
Why?
|
Brain Stem | 1 | 2013 | 846 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 21827 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2618 | 0.080 |
Why?
|
Mobility Limitation | 1 | 2011 | 409 | 0.080 |
Why?
|
ROC Curve | 1 | 2015 | 3527 | 0.070 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2013 | 770 | 0.070 |
Why?
|
Iridium Radioisotopes | 1 | 2006 | 26 | 0.070 |
Why?
|
Prognosis | 6 | 2023 | 29063 | 0.070 |
Why?
|
Gastroscopy | 1 | 2008 | 207 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15540 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5217 | 0.070 |
Why?
|
Seroepidemiologic Studies | 1 | 2008 | 401 | 0.070 |
Why?
|
Tissue Distribution | 1 | 2010 | 2327 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3297 | 0.070 |
Why?
|
Cholangiography | 1 | 2006 | 189 | 0.070 |
Why?
|
Adenoma, Islet Cell | 1 | 2005 | 82 | 0.070 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2005 | 41 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2017 | 1917 | 0.070 |
Why?
|
Retinal Ganglion Cells | 1 | 2011 | 770 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4665 | 0.070 |
Why?
|
Seasons | 1 | 2011 | 1493 | 0.070 |
Why?
|
Decision Making | 1 | 2019 | 3887 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2014 | 1838 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3086 | 0.070 |
Why?
|
Cognition Disorders | 2 | 2018 | 4043 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2010 | 1730 | 0.060 |
Why?
|
Cystadenoma, Serous | 1 | 2005 | 102 | 0.060 |
Why?
|
Retina | 2 | 2013 | 2616 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2305 | 0.060 |
Why?
|
Histocytological Preparation Techniques | 1 | 2004 | 30 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3508 | 0.060 |
Why?
|
Pliability | 1 | 2004 | 63 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7149 | 0.060 |
Why?
|
Tissue and Organ Harvesting | 1 | 2007 | 369 | 0.060 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.060 |
Why?
|
Video Recording | 1 | 2009 | 949 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2020 | 5078 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3309 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2861 | 0.060 |
Why?
|
Plastics | 1 | 2004 | 123 | 0.060 |
Why?
|
Muscle, Smooth | 1 | 2007 | 934 | 0.060 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2007 | 506 | 0.060 |
Why?
|
Comorbidity | 1 | 2017 | 10388 | 0.060 |
Why?
|
Proton Pump Inhibitors | 1 | 2008 | 526 | 0.060 |
Why?
|
Infant | 2 | 2017 | 35136 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2011 | 812 | 0.050 |
Why?
|
Peptides | 1 | 2015 | 4409 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2008 | 1641 | 0.050 |
Why?
|
Antigens, CD | 1 | 2013 | 4026 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20129 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7913 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 25043 | 0.050 |
Why?
|
Rats | 1 | 2018 | 24260 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2017 | 21746 | 0.050 |
Why?
|
Pregnancy | 3 | 2019 | 29144 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4253 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2014 | 2958 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2019 | 25625 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5137 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5097 | 0.050 |
Why?
|
Culture Media | 1 | 2022 | 908 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13881 | 0.050 |
Why?
|
Materials Testing | 1 | 2004 | 867 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 3760 | 0.050 |
Why?
|
Mice | 4 | 2016 | 81183 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2006 | 2879 | 0.040 |
Why?
|
Cladribine | 1 | 2019 | 34 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1107 | 0.040 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2020 | 295 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 15226 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1643 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1085 | 0.040 |
Why?
|
Consensus | 1 | 2007 | 2959 | 0.040 |
Why?
|
Gallbladder | 1 | 2019 | 302 | 0.040 |
Why?
|
Hospitalization | 1 | 2017 | 10262 | 0.040 |
Why?
|
Visual Acuity | 2 | 2019 | 2530 | 0.040 |
Why?
|
Minnesota | 1 | 2018 | 344 | 0.040 |
Why?
|
Cholecystectomy | 1 | 2019 | 395 | 0.040 |
Why?
|
Databases, Factual | 1 | 2012 | 7729 | 0.040 |
Why?
|
Blood Glucose | 1 | 2011 | 6256 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 730 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2019 | 769 | 0.040 |
Why?
|
Organoids | 1 | 2022 | 701 | 0.040 |
Why?
|
Expert Testimony | 1 | 2018 | 356 | 0.030 |
Why?
|
Catheterization | 1 | 2021 | 1470 | 0.030 |
Why?
|
Syndrome | 2 | 2015 | 3251 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2016 | 311 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1341 | 0.030 |
Why?
|
Equipment Design | 1 | 2004 | 3582 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2005 | 1583 | 0.030 |
Why?
|
Nausea | 1 | 2018 | 673 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 591 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2006 | 2728 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2018 | 1799 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1842 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11366 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2017 | 930 | 0.030 |
Why?
|
Contrast Media | 2 | 2019 | 5300 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2018 | 6993 | 0.030 |
Why?
|
Cell Death | 1 | 2019 | 1706 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2021 | 1990 | 0.030 |
Why?
|
Aging | 1 | 2011 | 8664 | 0.030 |
Why?
|
Endoscopy | 1 | 2022 | 1785 | 0.030 |
Why?
|
Vision Tests | 1 | 2013 | 167 | 0.030 |
Why?
|
Ultrasonography | 1 | 2005 | 5985 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2699 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 3610 | 0.030 |
Why?
|
Body Composition | 1 | 2021 | 2401 | 0.030 |
Why?
|
International Cooperation | 1 | 2018 | 1420 | 0.030 |
Why?
|
Pancreatitis | 2 | 2011 | 1092 | 0.030 |
Why?
|
Chronic Disease | 1 | 2007 | 9146 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1988 | 0.030 |
Why?
|
Lymphocytes | 1 | 2019 | 2617 | 0.030 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2011 | 87 | 0.020 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 961 | 0.020 |
Why?
|
Serologic Tests | 1 | 2013 | 374 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16365 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4217 | 0.020 |
Why?
|
Headache | 1 | 2019 | 1226 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9734 | 0.020 |
Why?
|
Spleen | 1 | 2016 | 2362 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 766 | 0.020 |
Why?
|
North America | 1 | 2013 | 1249 | 0.020 |
Why?
|
United States | 2 | 2020 | 69872 | 0.020 |
Why?
|
Survival Rate | 1 | 2004 | 12788 | 0.020 |
Why?
|
Japan | 1 | 2013 | 1360 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4161 | 0.020 |
Why?
|
Macular Edema | 1 | 2013 | 359 | 0.020 |
Why?
|
Weight Loss | 1 | 2020 | 2622 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2043 | 0.020 |
Why?
|
Duodenum | 1 | 2011 | 483 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2214 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2016 | 2258 | 0.020 |
Why?
|
Molecular Mimicry | 1 | 2008 | 201 | 0.020 |
Why?
|
Stomach | 1 | 2011 | 697 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2008 | 315 | 0.020 |
Why?
|
Body Water | 1 | 2008 | 343 | 0.020 |
Why?
|
Cochlea | 1 | 2013 | 828 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3339 | 0.020 |
Why?
|
Dyspepsia | 1 | 2007 | 115 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3558 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 19229 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6038 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3064 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8428 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2016 | 2133 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2023 | 15295 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9438 | 0.020 |
Why?
|
Axons | 1 | 2011 | 1684 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 2505 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16689 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3327 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 2005 | 413 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 2008 | 1017 | 0.010 |
Why?
|
Epitopes | 1 | 2008 | 2571 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9239 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 2031 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2008 | 1063 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10481 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4468 | 0.010 |
Why?
|
Astrocytes | 1 | 2008 | 1270 | 0.010 |
Why?
|
Protein Conformation | 1 | 2008 | 4011 | 0.010 |
Why?
|
Models, Neurological | 1 | 2008 | 1774 | 0.010 |
Why?
|
Laparoscopy | 1 | 2011 | 2151 | 0.010 |
Why?
|
Length of Stay | 1 | 2011 | 6309 | 0.010 |
Why?
|
Models, Molecular | 1 | 2008 | 5456 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13815 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2008 | 3479 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 18111 | 0.010 |
Why?
|